Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1995 Dec;79(12):1066–1067. doi: 10.1136/bjo.79.12.1066

Cytomegalovirus retinitis: are intraocular devices the answer?

A Tufail 1, G N Holland 1
PMCID: PMC505341  PMID: 8562536

Full text

PDF
1066

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand R., Nightingale S. D., Fish R. H., Smith T. J., Ashton P. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol. 1993 Feb;111(2):223–227. doi: 10.1001/archopht.1993.01090020077027. [DOI] [PubMed] [Google Scholar]
  2. Freeman W. R., Friedberg D. N., Berry C., Quiceno J. I., Behette M., Fullerton S. C., Munguia D. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol. 1993 Dec 15;116(6):713–720. doi: 10.1016/s0002-9394(14)73471-3. [DOI] [PubMed] [Google Scholar]
  3. Goodrich J. M., Mori M., Gleaves C. A., Du Mond C., Cays M., Ebeling D. F., Buhles W. C., DeArmond B., Meyers J. D. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med. 1991 Dec 5;325(23):1601–1607. doi: 10.1056/NEJM199112053252303. [DOI] [PubMed] [Google Scholar]
  4. Holland G. N., Sison R. F., Jatulis D. E., Haslop M. G., Sakamoto M. J., Wheeler N. C. Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. UCLA CMV Retinopathy Study Group. Ophthalmology. 1990 Feb;97(2):204–211. doi: 10.1016/s0161-6420(90)32616-7. [DOI] [PubMed] [Google Scholar]
  5. Jabs D. A., Enger C., Haller J., de Bustros S. Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol. 1991 Jun;109(6):794–799. doi: 10.1001/archopht.1991.01080060058024. [DOI] [PubMed] [Google Scholar]
  6. Jacobson M. A., Causey D., Polsky B., Hardy D., Chown M., Davis R., O'Donnell J. J., Kuppermann B. D., Heinemann M. H., Holland G. N. A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. J Infect Dis. 1993 Aug;168(2):444–448. doi: 10.1093/infdis/168.2.444. [DOI] [PubMed] [Google Scholar]
  7. Martin D. F., Parks D. J., Mellow S. D., Ferris F. L., Walton R. C., Remaley N. A., Chew E. Y., Ashton P., Davis M. D., Nussenblatt R. B. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial. Arch Ophthalmol. 1994 Dec;112(12):1531–1539. doi: 10.1001/archopht.1994.01090240037023. [DOI] [PubMed] [Google Scholar]
  8. Morley M. G., Duker J. S., Ashton P., Robinson M. R. Replacing ganciclovir implants. Ophthalmology. 1995 Mar;102(3):388–392. doi: 10.1016/s0161-6420(95)31010-x. [DOI] [PubMed] [Google Scholar]
  9. Singh N., Yu V. L., Mieles L., Wagener M. M., Miner R. C., Gayowski T. High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial. Ann Intern Med. 1994 Mar 1;120(5):375–381. doi: 10.7326/0003-4819-120-5-199403010-00004. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES